Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intraocular pressure increased, Laboratory test normal, Magnetic resonance imaging head normal, Nausea, Sleep disorder
Clinical narrative: loosing sight in her left eye/ had no vision in the left eye; left eye pain/ pain was severe/ about in 9 on a scale of 1 to 10; Booster; Didn''t sleep well; Headache; Chills; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Nov2021 13:00 (Lot number: FJ1620) at the age of 56 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "recurrent PE" (unspecified if ongoing). Concomitant medication(s) included: XARELTO taken for pulmonary embolism. Vaccination history included: Bnt162b2 (1st dose, lot#EL3247), administration date: 31Jan2021, when the patient was 55 years old, for COVID-19 Immunization, reaction(s): "headache", "chills"; Bnt162b2 (2nd dose, lot#EN5318), administration date: 21Feb2021, when the patient was 55 years old, for COVID-19 Immunization, reaction(s): "headache", "chills"; Tdap vaccine (tdap vaccine), administration date: Sep2021. The following information was reported: IMMUNISATION (medically significant) with onset 19Nov2021 13:00, outcome "unknown", described as "Booster"; BLINDNESS UNILATERAL (medically significant) with onset 20Nov2021, outcome "unknown", described as "loosing sight in her left eye/ had no vision in the left eye"; EYE PAIN (medically significant) with onset 20Nov2021, outcome "unknown", described as "left eye pain/ pain was severe/ about in 9 on a scale of 1 to 10"; HEADACHE (non-serious) with onset 19Nov2021, outcome "unknown", described as "Headache"; CHILLS (non-serious) with onset 19Nov2021, outcome "unknown", described as "Chills"; POOR QUALITY SLEEP (non-serious) with onset 19Nov2021, outcome "unknown", described as "Didn''t sleep well". The events "loosing sight in her left eye/ had no vision in the left eye", "left eye pain/ pain was severe/ about in 9 on a scale of 1 to 10", "headache", "chills" and "didn''t sleep well" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: investigation: (19Nov2021) unknown result, notes: had plenty of lab tests in the hospital on the 19th, 20th, and 21st; (20Nov2021) unknown result, notes: had plenty of lab tests in the hospital on the 19th, 20th, and 21st; (21Nov2021) unknown result, notes: had plenty of lab tests in the hospital on the 19th, 20th, and 21st; pain assessment (1-10): (19Nov2021) 9, notes: It was about in 9 on a scale of 1 to 10. Therapeutic measures were taken as a result of blindness unilateral, eye pain, headache, chills, poor quality sleep included: given Tylenol 650 milligrams, one tablet. Clinical course: The patient received the Pfizer COVID-19, booster shot on the recommendation of doctor, she got it at 1 O'clock in the afternoon and she went to bed about 9 O'clock or 9:30 in the evening with a headache. She had a few chills. She really didn't sleep well and woke up about 6:30 in the morning with a really bad headache and left eye pain. The pain was severe. It was about in 9 on a scale of 1 to 10. She was loosing sight in her left eye and called doctor and he told to go to the emergency room and the patient did that and after close to 48 hours. She had no vision in the left eye. She didn't know if this was a side effect but you know she had the vaccine and in less than 24 hours she lost her sight in her left eye.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101700060 same patient/drug, different event (dose 1 and dose 2)